Filing Flows › Medicinova (MNOV) › Q2 2026 › vs Q2 2025
Medicinova (MNOV) Q2 2026 vs Q2 2025 (year over year)
Medicinova's revenue rose $324K (+241%) from $135K in Q2 2025 to $458K in Q2 2026.
Medicinova, Q2 2026: revenue $458K (+241% year over year), operating margin -554.3%, net loss $2.3M, operating cash flow −$1.9M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $458K | $135K | $324K | +241% |
| Other income, net | $227K | $326K | −$99K | -30% |
| Net loss | $2.3M | $3.3M | −$967K | -29% |
| Costs & expenses | $3.0M | $3.7M | −$742K | -20% |
| Operating costs | $3.0M | $3.7M | −$742K | -20% |
| Research & development | $900K | $2.0M | −$1.1M | -55% |
| Sales & marketing | $141K | $116K | $24K | +21% |
| General & admin | $1.8M | $1.4M | $393K | +27% |
| Other operating costs | $129K | $189K | −$59K | -32% |
| Operating cash sources | $2.3M | $3.3M | −$967K | -29% |
| Depreciation & amortization | $5K | $5K | −$44 | -0.9% |
| Share-based compensation | $177K | $205K | −$28K | -14% |
| Working capital & other | $212K | $765K | −$553K | -72% |
| Cash used in operations | $1.9M | $2.3M | −$386K | -17% |
| Net loss absorbed | $2.3M | $3.3M | −$967K | -29% |
Questions
How much did Medicinova's revenue grow year over year in Q2 2026?
Medicinova's revenue rose $324K (+241%) from $135K in Q2 2025 to $458K in Q2 2026.